Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.

Kim, K I; Sasase, N; Taniguchi, M; Mita, K; Kinoshita, K; Togitani, T; Shikata, M; Kimura, N; Izawa, S; Ohtani, A; Nakao, K; Muramoto, Y; Kim, S R; Nabeshima, S; Ishii, F; Tanaka, K; Hayashi, Y

Kim, K I; Sasase, N; Taniguchi, M; Mita, K; Kinoshita, K; Togitani, T; Shikata, M; Kimura, N; Izawa, S; Ohtani, A; Nakao, K; Muramoto, Y; Kim, S R; Nabeshima, S; Ishii, F; Tanaka, K; Hayashi, Y.

Affiliation

Kim KI; Division of Molecular Medicine & Medical Genetics, International Center for Medical Research and Treatment, Kobe University Graduate School of Medicine, Kobe, Japan.

Int J Clin Pharmacol Res ; 25(2): 71-6, 2005.

Article in En | MEDLINE | ID: mdl-16060397

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ribavirin / Interferon-beta / Interferon-alpha / Hepatitis C, Chronic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pharmacol Res Year: 2005 Document type: Article Affiliation country: Japón Country of publication: Suiza

Search on Google

Add to My VHL

XML

PubMed Links